| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | G protein-coupled photoreceptor activity | 2.35e-06 | 15 | 132 | 4 | GO:0008020 | |
| GeneOntologyMolecularFunction | photoreceptor activity | 4.06e-06 | 17 | 132 | 4 | GO:0009881 | |
| GeneOntologyMolecularFunction | integrin binding | 1.65e-04 | 175 | 132 | 7 | GO:0005178 | |
| GeneOntologyMolecularFunction | phosphatidylinositol phosphate binding | 3.62e-04 | 199 | 132 | 7 | GO:1901981 | |
| GeneOntologyMolecularFunction | cytoskeleton-nuclear membrane anchor activity | 4.28e-04 | 5 | 132 | 2 | GO:0140444 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | MYO1B GLOD4 UNC45A ITGA7 ITGAM FBLN1 BAIAP2L1 EGFR TSPAN4 MACF1 KDR ADAM2 | 6.30e-04 | 599 | 132 | 12 | GO:0050839 |
| GeneOntologyMolecularFunction | vascular endothelial growth factor binding | 6.39e-04 | 6 | 132 | 2 | GO:0038085 | |
| GeneOntologyCellularComponent | photoreceptor disc membrane | 1.81e-05 | 26 | 128 | 4 | GO:0097381 | |
| GeneOntologyCellularComponent | P-body | 4.12e-04 | 102 | 128 | 5 | GO:0000932 | |
| GeneOntologyCellularComponent | CCR4-NOT core complex | 5.49e-04 | 6 | 128 | 2 | GO:0030015 | |
| GeneOntologyCellularComponent | ooplasm | 5.49e-04 | 6 | 128 | 2 | GO:1990917 | |
| HumanPheno | Abnormal cardiac ventricle morphology | MYLK TRIO NSD2 SYNE1 HMGCR ITGA7 CPT2 NSMCE2 MAPKAPK5 NEK9 RYR3 GTF2I EGFR VPS35L CKAP2L MACF1 EIF2AK4 SEMA4A EXOC2 FHL1 TOP3A CAP2 HNRNPR | 2.30e-07 | 780 | 50 | 23 | HP:0001713 |
| Domain | Opsin_red/grn | 3.14e-07 | 3 | 128 | 3 | IPR000378 | |
| Domain | Spectrin | 1.68e-05 | 23 | 128 | 4 | PF00435 | |
| Domain | OPSIN | 3.64e-05 | 10 | 128 | 3 | PS00238 | |
| Domain | Spectrin_repeat | 4.38e-05 | 29 | 128 | 4 | IPR002017 | |
| Domain | Opsin | 4.98e-05 | 11 | 128 | 3 | IPR001760 | |
| Domain | SPEC | 6.52e-05 | 32 | 128 | 4 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 6.52e-05 | 32 | 128 | 4 | IPR018159 | |
| Domain | KASH | 2.77e-04 | 4 | 128 | 2 | IPR012315 | |
| Domain | KASH | 2.77e-04 | 4 | 128 | 2 | PS51049 | |
| Domain | KASH | 2.77e-04 | 4 | 128 | 2 | SM01249 | |
| Domain | KASH | 2.77e-04 | 4 | 128 | 2 | PF10541 | |
| Domain | FG_GAP | 4.40e-04 | 22 | 128 | 3 | PS51470 | |
| Domain | RNase_CAF1 | 4.60e-04 | 5 | 128 | 2 | IPR006941 | |
| Domain | CAF1 | 4.60e-04 | 5 | 128 | 2 | PF04857 | |
| Domain | FG-GAP | 5.73e-04 | 24 | 128 | 3 | PF01839 | |
| Domain | FG-GAP | 5.73e-04 | 24 | 128 | 3 | IPR013517 | |
| Pathway | REACTOME_THE_RETINOID_CYCLE_IN_CONES_DAYLIGHT_VISION | 2.01e-05 | 8 | 102 | 3 | MM14880 | |
| Pathway | REACTOME_OPSINS | 4.25e-05 | 10 | 102 | 3 | MM15063 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | FLOT2 TRIO NSD2 ANP32B USP9X SYNE1 POLR2B MYO1B MSH3 GLOD4 UNC45A NEK9 DDX1 CDCA2 CCT6A ZC3H11A GTF2I STIP1 HSD17B10 FHL1 HNRNPLL CLUH NUP160 MCOLN2 HNRNPR | 1.72e-10 | 1425 | 133 | 25 | 30948266 |
| Pubmed | Human L- and M-opsins restore M-cone function in a mouse model for human blue cone monochromacy. | 2.04e-10 | 4 | 133 | 4 | 29386880 | |
| Pubmed | Molecular genetics of human color vision: the genes encoding blue, green, and red pigments. | 1.02e-09 | 5 | 133 | 4 | 2937147 | |
| Pubmed | RAD51 PDGFRA ITFG2 YBEY USP9X POLR2B HMGCR MAPKAPK5 TAS2R42 CCT6A ZC3H11A GTF2I SCAPER CKAP2L FLCN STIP1 HSD17B10 EIF2AK4 HECTD1 RAB5C HNRNPR | 3.50e-08 | 1327 | 133 | 21 | 32694731 | |
| Pubmed | Multiple hypothalamic cell populations encoding distinct visual information. | 5.47e-08 | 3 | 133 | 3 | 21224225 | |
| Pubmed | Circadian Regulation of the Rod Contribution to Mesopic Vision in Mice. | 5.47e-08 | 3 | 133 | 3 | 36216501 | |
| Pubmed | 5.47e-08 | 3 | 133 | 3 | 34111401 | ||
| Pubmed | Gene-based Therapy in a Mouse Model of Blue Cone Monochromacy. | 5.47e-08 | 3 | 133 | 3 | 28751656 | |
| Pubmed | The molecular genetics and evolution of red and green color vision in vertebrates. | 5.47e-08 | 3 | 133 | 3 | 11545071 | |
| Pubmed | Co-expression of murine opsins facilitates identifying the site of cone adaptation. | 5.47e-08 | 3 | 133 | 3 | 12511072 | |
| Pubmed | Molecular characterization of EGFR, PDGFRA and VEGFR2 in cervical adenosquamous carcinoma. | 5.47e-08 | 3 | 133 | 3 | 19563658 | |
| Pubmed | Molecular determinants of human red/green color discrimination. | 5.47e-08 | 3 | 133 | 3 | 8185948 | |
| Pubmed | X-linked cone dystrophy caused by mutation of the red and green cone opsins. | 5.47e-08 | 3 | 133 | 3 | 20579627 | |
| Pubmed | 5.47e-08 | 3 | 133 | 3 | 38410159 | ||
| Pubmed | Chloride-dependent spectral tuning mechanism of L-group cone visual pigments. | 5.47e-08 | 3 | 133 | 3 | 23350963 | |
| Pubmed | Distinct contributions of rod, cone, and melanopsin photoreceptors to encoding irradiance. | 5.47e-08 | 3 | 133 | 3 | 20471354 | |
| Pubmed | Spectral tuning of a circadian photopigment in a subterranean 'blind' mammal (Spalax ehrenbergi). | 5.47e-08 | 3 | 133 | 3 | 10567724 | |
| Pubmed | 5.47e-08 | 3 | 133 | 3 | 14500905 | ||
| Pubmed | Rescue of M-cone Function in Aged Opn1mw-/- Mice, a Model for Late-Stage Blue Cone Monochromacy. | 5.47e-08 | 3 | 133 | 3 | 31469404 | |
| Pubmed | Mechanisms of spectral tuning in the mouse green cone pigment. | 5.47e-08 | 3 | 133 | 3 | 9238068 | |
| Pubmed | Emergence of novel color vision in mice engineered to express a human cone photopigment. | 5.47e-08 | 3 | 133 | 3 | 17379811 | |
| Pubmed | 5.47e-08 | 3 | 133 | 3 | 7958444 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | KIF13B TTC28 USP9X ZGRF1 MYO1B WASHC2A DDX1 BAIAP2L1 LMO7 MACF1 STIP1 HSD17B10 TOP3A HNRNPR | 6.48e-08 | 588 | 133 | 14 | 38580884 |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | USP9X MSH3 DDX1 CCT6A ZC3H11A GTF2I LMO7 STIP1 HNRNPLL NUP160 HNRNPR | 6.81e-08 | 332 | 133 | 11 | 32786267 |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | ANP32B USP9X POLR2B MYO1B UNC45A CPT2 NEK9 DDX1 CCT6A GTF2I LMO7 OTUD4 MACF1 STIP1 HSD17B10 FHL1 EXOC7 RAB5C HNRNPR | 8.56e-08 | 1149 | 133 | 19 | 35446349 |
| Pubmed | USP9X POLR2B UNC45A NEK9 DDX1 CSDE1 CCT6A GTF2I STIP1 HSD17B10 HECTD1 NUP160 RAB5C HNRNPR | 1.75e-07 | 638 | 133 | 14 | 33239621 | |
| Pubmed | 2.18e-07 | 4 | 133 | 3 | 28103478 | ||
| Pubmed | 2.18e-07 | 4 | 133 | 3 | 3303660 | ||
| Pubmed | 2.18e-07 | 4 | 133 | 3 | 26438865 | ||
| Pubmed | 2.18e-07 | 4 | 133 | 3 | 17249565 | ||
| Pubmed | 2.18e-07 | 4 | 133 | 3 | 38060327 | ||
| Pubmed | Contribution of M-opsin-based color vision to refractive development in mice. | 2.18e-07 | 4 | 133 | 3 | 34126082 | |
| Pubmed | 2.18e-07 | 4 | 133 | 3 | 31461375 | ||
| Pubmed | 2.18e-07 | 4 | 133 | 3 | 8088841 | ||
| Pubmed | 2.18e-07 | 4 | 133 | 3 | 31846668 | ||
| Pubmed | 2.18e-07 | 4 | 133 | 3 | 16567464 | ||
| Pubmed | S-opsin knockout mice with the endogenous M-opsin gene replaced by an L-opsin variant. | 2.18e-07 | 4 | 133 | 3 | 24801621 | |
| Pubmed | Melanopsin Contributions to the Representation of Images in the Early Visual System. | 2.18e-07 | 4 | 133 | 3 | 28528909 | |
| Pubmed | 2.18e-07 | 4 | 133 | 3 | 25308073 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | DOCK1 TRIO NSD2 ST7 TSNARE1 NSMCE2 NEK9 ZNF595 CSDE1 ZC3H11A GTF2I LRFN2 TESMIN EGFR VPS35L OSBPL5 TSPAN4 MACF1 EIF2AK4 HECTD1 CAP2 | 2.40e-07 | 1489 | 133 | 21 | 28611215 |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | ANP32B USP9X POLR2B GLOD4 UNC45A NEK9 DDX1 CSDE1 CCT6A GTF2I BAIAP2L1 EGFR MACF1 STIP1 HSD17B10 EXOC2 HECTD1 CLUH RAB5C HNRNPR | 4.63e-07 | 1415 | 133 | 20 | 28515276 |
| Pubmed | COL6A3 ZBTB38 CTTNBP2 TRIO SYNE1 LRRC2 NEK9 CCT6A MACF1 STIP1 FHL1 HNRNPR | 5.11e-07 | 497 | 133 | 12 | 23414517 | |
| Pubmed | Using Silent Substitution to Track the Mesopic Transition From Rod- to Cone-Based Vision in Mice. | 5.44e-07 | 5 | 133 | 3 | 26818794 | |
| Pubmed | 5.44e-07 | 5 | 133 | 3 | 22090509 | ||
| Pubmed | Peripherin-2 differentially interacts with cone opsins in outer segments of cone photoreceptors. | 5.44e-07 | 5 | 133 | 3 | 27033727 | |
| Pubmed | 5.44e-07 | 5 | 133 | 3 | 11055434 | ||
| Pubmed | Noncoding Mutations in a Thyroid Hormone Receptor Gene That Impair Cone Photoreceptor Function. | 5.44e-07 | 5 | 133 | 3 | 36631163 | |
| Pubmed | A common integration locus in type B retrovirus-induced thymic lymphomas. | 5.44e-07 | 5 | 133 | 3 | 1333116 | |
| Pubmed | Comparative sequence analysis of the MECP2-locus in human and mouse reveals new transcribed regions. | 5.44e-07 | 5 | 133 | 3 | 10723722 | |
| Pubmed | Melanopsin-based brightness discrimination in mice and humans. | 5.44e-07 | 5 | 133 | 3 | 22633808 | |
| Pubmed | 5.44e-07 | 5 | 133 | 3 | 24058409 | ||
| Pubmed | Variations in photoreceptor throughput to mouse visual cortex and the unique effects on tuning. | 5.44e-07 | 5 | 133 | 3 | 34099749 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | RAD51 ANP32B USP9X POLR2B IREB2 UNC45A WASHC2A NEK9 DDX1 CSDE1 CCT6A GTF2I MACF1 STIP1 HSD17B10 HECTD1 CLUH NUP160 CAP2 HNRNPR | 7.15e-07 | 1455 | 133 | 20 | 22863883 |
| Pubmed | Reduced levels of dystrophin associated proteins in the brains of mice deficient for Dp71. | 1.08e-06 | 6 | 133 | 3 | 8872469 | |
| Pubmed | A thyroid hormone receptor that is required for the development of green cone photoreceptors. | 1.08e-06 | 6 | 133 | 3 | 11138006 | |
| Pubmed | Functional comparison of rod and cone Gα(t) on the regulation of light sensitivity. | 1.08e-06 | 6 | 133 | 3 | 23288843 | |
| Pubmed | Impaired cytokine signaling in mice lacking the IL-1 receptor-associated kinase. | 1.08e-06 | 6 | 133 | 3 | 10395695 | |
| Pubmed | 1.08e-06 | 6 | 133 | 3 | 17436273 | ||
| Pubmed | Telomere-related markers for the pseudoautosomal region of the mouse genome. | 1.08e-06 | 6 | 133 | 3 | 1549575 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | KIF13B FLOT2 TTC28 TRIO PDGFRA UNC45A NSMCE2 NEK9 DDX1 GAB2 CDCA2 BAIAP2L1 LMO7 MACF1 HECTD1 | 1.15e-06 | 861 | 133 | 15 | 36931259 |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | NSD2 POLR2B ZKSCAN8 DDX1 CDCA2 CSDE1 ZC3H11A SCAPER CKAP2L MACF1 EXOC7 HECTD1 NOL8 HNRNPR | 1.38e-06 | 759 | 133 | 14 | 35915203 |
| Pubmed | 1.89e-06 | 7 | 133 | 3 | 18199774 | ||
| Pubmed | 1.89e-06 | 7 | 133 | 3 | 8378320 | ||
| Pubmed | Rod Photoreceptor Activation Alone Defines the Release of Dopamine in the Retina. | 1.89e-06 | 7 | 133 | 3 | 30799247 | |
| Pubmed | 1.89e-06 | 7 | 133 | 3 | 16574740 | ||
| Pubmed | 1.89e-06 | 7 | 133 | 3 | 19332056 | ||
| Pubmed | Retarded developmental expression and patterning of retinal cone opsins in hypothyroid mice. | 1.89e-06 | 7 | 133 | 3 | 18974269 | |
| Pubmed | 1.89e-06 | 7 | 133 | 3 | 8001979 | ||
| Pubmed | Mapping of the murine tbl1 gene reveals a new rearrangement between mouse and human X Chromosomes. | 1.89e-06 | 7 | 133 | 3 | 9880679 | |
| Pubmed | Rods progressively escape saturation to drive visual responses in daylight conditions. | 1.89e-06 | 7 | 133 | 3 | 29180667 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | FLOT2 USP9X SYNE1 POLR2B MYO1B DDX1 CCT6A ZC3H11A LMO7 CKAP2L MACF1 STIP1 HSD17B10 NUP160 RAB5C HNRNPR | 2.03e-06 | 1024 | 133 | 16 | 24711643 |
| Pubmed | ZBTB38 TTC28 TRIO USP9X SYNE1 MSH3 RYR3 CNOT8 CSDE1 LMO7 ASB3 VPS35L MACF1 FHL1 EXOC7 HECTD1 ZMYM5 CAP2 | 2.09e-06 | 1285 | 133 | 18 | 35914814 | |
| Pubmed | Biochemical Reduction of the Topology of the Diverse WDR76 Protein Interactome. | 2.17e-06 | 219 | 133 | 8 | 31353912 | |
| Pubmed | 2.43e-06 | 25 | 133 | 4 | 33795534 | ||
| Pubmed | FLOT2 ANP32B ST7 POLR2B MYO1B HMGCR UNC45A DDX1 CSDE1 CCT6A GTF2I LMO7 CNOT7 VPS35L STIP1 HSD17B10 EXOC2 EXOC7 HNRNPR | 2.54e-06 | 1440 | 133 | 19 | 30833792 | |
| Pubmed | Localization of the mdx mutation within the mouse dystrophin gene. | 3.02e-06 | 8 | 133 | 3 | 2903046 | |
| Pubmed | 3.02e-06 | 8 | 133 | 3 | 1572654 | ||
| Pubmed | 3.02e-06 | 8 | 133 | 3 | 21813673 | ||
| Pubmed | 3.02e-06 | 8 | 133 | 3 | 31163126 | ||
| Pubmed | 3.02e-06 | 8 | 133 | 3 | 20203194 | ||
| Pubmed | Tubby is required for trafficking G protein-coupled receptors to neuronal cilia. | 3.02e-06 | 8 | 133 | 3 | 23351594 | |
| Pubmed | 3.02e-06 | 8 | 133 | 3 | 10725384 | ||
| Pubmed | 3.02e-06 | 8 | 133 | 3 | 33007388 | ||
| Pubmed | Linkage of amelogenin (Amel) to the distal portion of the mouse X chromosome. | 3.02e-06 | 8 | 133 | 3 | 1675194 | |
| Pubmed | 3.02e-06 | 8 | 133 | 3 | 3416629 | ||
| Pubmed | 3.02e-06 | 8 | 133 | 3 | 12651948 | ||
| Pubmed | 3.02e-06 | 8 | 133 | 3 | 16043864 | ||
| Pubmed | 3.35e-06 | 27 | 133 | 4 | 23001562 | ||
| Pubmed | DOCK1 FLOT2 TTC28 USP9X MYO1B UNC45A CSDE1 CCT6A BAIAP2L1 EGFR MACF1 STIP1 HSD17B10 | 3.52e-06 | 708 | 133 | 13 | 39231216 | |
| Pubmed | LRCH2 MYO1B WASHC2A NEK9 DDX1 CCT6A GTF2I BAIAP2L1 LMO7 CKAP2L CAP2 | 4.25e-06 | 506 | 133 | 11 | 30890647 | |
| Pubmed | ZBED4, a cone and Müller cell protein in human retina, has a different cellular expression in mouse. | 4.52e-06 | 9 | 133 | 3 | 21850176 | |
| Pubmed | 4.52e-06 | 9 | 133 | 3 | 28370415 | ||
| Pubmed | IFT20 is required for opsin trafficking and photoreceptor outer segment development. | 4.52e-06 | 9 | 133 | 3 | 21307337 | |
| Pubmed | 4.52e-06 | 9 | 133 | 3 | 2906327 | ||
| Pubmed | 4.52e-06 | 9 | 133 | 3 | 1973136 | ||
| Pubmed | Retinal dystrophy resulting from ablation of RXR alpha in the mouse retinal pigment epithelium. | 4.52e-06 | 9 | 133 | 3 | 14742273 | |
| Pubmed | 4.52e-06 | 9 | 133 | 3 | 25296752 | ||
| Pubmed | Comparative mapping of the actin-binding protein 280 genes in human and mouse. | 4.52e-06 | 9 | 133 | 3 | 8088838 | |
| Pubmed | 4.52e-06 | 9 | 133 | 3 | 27669145 | ||
| Pubmed | 4.52e-06 | 9 | 133 | 3 | 12407160 | ||
| Interaction | SUMO2 interactions | RAD51 ANP32B USP9X MSH3 DDX1 CCT6A ZC3H11A GTF2I EGFR LMO7 STIP1 HSD17B10 HNRNPLL NUP160 ZMYM5 HNRNPR | 1.35e-06 | 591 | 130 | 16 | int:SUMO2 |
| Interaction | EED interactions | FLOT2 TRIO NSD2 ANP32B USP9X POLR2B MYO1B MSH3 UNC45A NEK9 DDX1 CCT6A ZC3H11A GTF2I VPS35L MACF1 EXOC2 FHL1 HECTD1 HNRNPLL CLUH NUP160 RAB5C HNRNPR | 1.59e-05 | 1445 | 130 | 24 | int:EED |
| Interaction | HECTD1 interactions | RAD51 TTC28 NSD2 USP9X POLR2B ZKSCAN8 DDX1 CDCA2 CSDE1 ZC3H11A SCAPER CKAP2L MACF1 STIP1 EXOC2 EXOC7 HECTD1 NOL8 HNRNPR | 1.81e-05 | 984 | 130 | 19 | int:HECTD1 |
| GeneFamily | Opsin receptors | 2.94e-07 | 11 | 101 | 4 | 215 | |
| GeneFamily | Spectrin repeat containing nuclear envelope family | 1.84e-04 | 4 | 101 | 2 | 1252 | |
| GeneFamily | Zinc fingers GRF-type|Topoisomerases | 6.37e-04 | 7 | 101 | 2 | 135 | |
| GeneFamily | Myosins, class I | 8.46e-04 | 8 | 101 | 2 | 1097 | |
| GeneFamily | Zinc fingers CCCH-type | 9.73e-04 | 35 | 101 | 3 | 73 | |
| GeneFamily | Exocyst complex | 1.08e-03 | 9 | 101 | 2 | 1055 | |
| GeneFamily | CCR4-NOT transcription complex | 1.64e-03 | 11 | 101 | 2 | 1023 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 2.10e-03 | 161 | 101 | 5 | 593 | |
| GeneFamily | CD molecules|Integrin alpha subunits | 4.46e-03 | 18 | 101 | 2 | 1160 | |
| Coexpression | GSE27786_LIN_NEG_VS_NKTCELL_UP | NSD2 ANP32B ST7 CPT2 LDLRAD3 GAB2 CDCA2 CKAP2L EXOC7 HNRNPLL | 5.97e-08 | 200 | 129 | 10 | M4787 |
| Coexpression | GSE20152_SPHK1_KO_VS_HTNFA_OVEREXPRESS_ANKLE_DN | 6.19e-06 | 197 | 129 | 8 | M7683 | |
| Coexpression | GSE39820_CTRL_VS_TGFBETA1_IL6_IL23A_CD4_TCELL_UP | 6.67e-06 | 199 | 129 | 8 | M5607 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 8.02e-09 | 199 | 131 | 9 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-Proliferating_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.70e-08 | 173 | 131 | 8 | 2eb6e9fc3a3654f6f86fbd112e80a18814afd103 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.38e-07 | 199 | 131 | 8 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 1.44e-07 | 200 | 131 | 8 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 1.44e-07 | 200 | 131 | 8 | bd8cf33502adea320e91ca2af14e1911d88ad374 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.91e-07 | 172 | 131 | 7 | d354424c1f861b6607dfd63b9724f4c237b30275 | |
| ToppCell | P28-Mesenchymal|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.15e-06 | 182 | 131 | 7 | 69f9d44694fe4f55a971ae0ac5dc3e7448ee78f3 | |
| ToppCell | 367C-Lymphocytic-NK_cells-Proliferating_NK_cell|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.20e-06 | 183 | 131 | 7 | a716b446c2bf5aa294b8f580aa845098fae76354 | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.65e-06 | 192 | 131 | 7 | d22c1135867bcb9076435e2c6eb1cc1248990d0c | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.65e-06 | 192 | 131 | 7 | c09966f4d63a739a56db4df7e0e0ee9ecacd21ad | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.71e-06 | 193 | 131 | 7 | 4c74a3f69b2cbdf139e7e66b44bd86869ac34dc0 | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-06 | 193 | 131 | 7 | 027e098ad018e782287f84eee0f77551018f2196 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.71e-06 | 193 | 131 | 7 | ff8ceeb3cfd1bef7239df490c19d181091750833 | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-06 | 193 | 131 | 7 | c5463a87f20b3a7f7ffda677b2f5a0e9e49d6685 | |
| ToppCell | PSB-critical-LOC-Epithelial-FOXN4+|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.71e-06 | 193 | 131 | 7 | b7d9c5bed524423e92f01496a9f8fad11b33a3f7 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.77e-06 | 194 | 131 | 7 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | COVID-19-Heart-Fib_1|Heart / Disease (COVID-19 only), tissue and cell type | 1.83e-06 | 195 | 131 | 7 | f423baa36ac7cdc383c033e35a7d17e6bf913323 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 1.83e-06 | 195 | 131 | 7 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 1.83e-06 | 195 | 131 | 7 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | facs-Thymus-Thymus_Epithelium|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-06 | 196 | 131 | 7 | 6bc1187dfc4860a4e09032d7ea87ba3d9fe9f363 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-06 | 196 | 131 | 7 | 66d76249bd2770cdddff2c1fe59a016e95da2124 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-06 | 196 | 131 | 7 | c8c89e469402e11aa2a9561e859b6fd1fb66c39b | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-06 | 196 | 131 | 7 | 9bd4c146fc7555e32adfa393b3a07846eb826d25 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 2.02e-06 | 198 | 131 | 7 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | 18-Airway-Mesenchymal-Mesenchyme_RSPO2+|Airway / Age, Tissue, Lineage and Cell class | 2.09e-06 | 199 | 131 | 7 | 7ac35e8f45dcdc702422dabd8f3e4d03e2bf61af | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.09e-06 | 199 | 131 | 7 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.09e-06 | 199 | 131 | 7 | e1849505b92820a219c5a2c35492bdd55579fb48 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.16e-06 | 200 | 131 | 7 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.16e-06 | 200 | 131 | 7 | b79628fd1386aa9a3b0e9fa81def0bc100c3c073 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.16e-06 | 200 | 131 | 7 | 50ca6550998e461ef26dd670351060bd940765a8 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | 2.16e-06 | 200 | 131 | 7 | 9d5b3c2dcfa55d50acc2ce2c319d51aa525d4cd1 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.16e-06 | 200 | 131 | 7 | 38e681997913fcbc93f4e1715820e53844376eab | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.16e-06 | 200 | 131 | 7 | 3dd022e974fec7013ba18f333da63f58fbf2dd7c | |
| ToppCell | facs-Aorta-Heart-3m-Myeloid-professional_antigen_presenting_cell|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.55e-06 | 139 | 131 | 6 | 292533e04178dd36d57377562077f9deb2cb9746 | |
| ToppCell | Megakaryocytic-erythropoietic-Erythro-cells-Erythrocyte|Erythro-cells / Lineage, cell class and subclass | 4.36e-06 | 144 | 131 | 6 | 7fbedc65314cfb06bcc527d794b5de7858f7c5ec | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.18e-06 | 164 | 131 | 6 | d167c7a987b9b35d1e7725c803df4f9cd5380e47 | |
| ToppCell | droplet-Heart-nan-24m-Hematologic-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-05 | 167 | 131 | 6 | bad33497ceeab968a7eb8a48b921c6f936390743 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Hematopoietic-Red_blood_cells-RBC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.20e-05 | 172 | 131 | 6 | acdc261001f63a8cfce1216ef1e33b4e034b1c11 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Hematopoietic-Red_blood_cells|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.20e-05 | 172 | 131 | 6 | 8ccc3459dbdf103c631aa2a0defb8790c06ad6c1 | |
| ToppCell | P15-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.29e-05 | 174 | 131 | 6 | 3c47d069bd836599a8d40eae485c23d4d3487517 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.42e-05 | 177 | 131 | 6 | 26c25d10aa511b64cc7db43a8deea7b5d31bca96 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-05 | 178 | 131 | 6 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Proliferating_Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.56e-05 | 180 | 131 | 6 | 43fd5c498a87bb078d101298b472656f3294686a | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.61e-05 | 181 | 131 | 6 | 9ede19228ba5c0668a9c06c915510b95585216ef | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.66e-05 | 182 | 131 | 6 | c557de6ccd327c46e0a5423cd9936d78e0abae5f | |
| ToppCell | P28-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.66e-05 | 182 | 131 | 6 | 19c5e3a9d9b3728303b682102e276adfe93aa759 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.66e-05 | 182 | 131 | 6 | dbe4b2557cf19e0682ed446f8397d3a1153642f0 | |
| ToppCell | 10x5'v1-week_17-19-Hematopoietic-erythroid|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.76e-05 | 184 | 131 | 6 | 0efc757d9512d6a8fe8176e977a94e4494ed9778 | |
| ToppCell | droplet-Lung-nan-3m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.76e-05 | 184 | 131 | 6 | 89ac32e374a4379e4a6c6ea7603b1378b77c147f | |
| ToppCell | P28-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.76e-05 | 184 | 131 | 6 | 924400f47e6b2cdf7b0d538df75857935cf0209b | |
| ToppCell | droplet-Lung-nan-3m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.76e-05 | 184 | 131 | 6 | 4df6027fa635996c1eddb920f88a5265772df1cd | |
| ToppCell | 21-Trachea-Mesenchymal-Airway_Smooth_Muscle|Trachea / Age, Tissue, Lineage and Cell class | 1.76e-05 | 184 | 131 | 6 | 86a96cd88e50eacad1f0badfbbf6dc626f41725e | |
| ToppCell | P15-Mesenchymal-mesenchymal_fibroblast|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.82e-05 | 185 | 131 | 6 | 46460e74cc613df9043f5404e7342aa13cc34873 | |
| ToppCell | ILEUM-inflamed-(8)_Fibroblast-(8)_Smooth_muscle_cells|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.88e-05 | 186 | 131 | 6 | cacc2f0b2ed46516173b61ba1c5c226a2db7cddc | |
| ToppCell | P15-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.88e-05 | 186 | 131 | 6 | 88e6246172d816806a498a5c1f38e699f2f5d7c2 | |
| ToppCell | severe_influenza-RBC|World / disease group, cell group and cell class (v2) | 1.93e-05 | 187 | 131 | 6 | f846750575f318503d21ade30f5bfd2e1d4c84af | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 1.93e-05 | 187 | 131 | 6 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | LAM-Endothelial-VasEndo-1|Endothelial / Condition, Lineage and Cell class | 1.99e-05 | 188 | 131 | 6 | f24c33d960ca93459584a79ff8f0ec20db6a34d5 | |
| ToppCell | Influenza_Severe-RBC|World / Disease group and Cell class | 1.99e-05 | 188 | 131 | 6 | f0438e6a77ee1f0456cb65926685266fff470983 | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.05e-05 | 189 | 131 | 6 | f7d57723b8fb0f1e1485f51e3eff93ec0f39761e | |
| ToppCell | facs-Lung-EPCAM-24m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.05e-05 | 189 | 131 | 6 | 324c81285c51f4f8bb1aef428b18fe2c549c2c11 | |
| ToppCell | E18.5-samps-Mesenchymal|E18.5-samps / Age Group, Lineage, Cell class and subclass | 2.05e-05 | 189 | 131 | 6 | 0c18d3de4720759cf802eefb4d0ddde2a9246a1a | |
| ToppCell | droplet-Lung-18m-Mesenchymal-fibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.05e-05 | 189 | 131 | 6 | e76dc36a01d8ad7590b3acc4c46abfcb76857448 | |
| ToppCell | facs-Lung-EPCAM-24m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.11e-05 | 190 | 131 | 6 | 00fd993675faf53adf985b9316a18c8a33242029 | |
| ToppCell | droplet-Lung-18m-Mesenchymal|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.11e-05 | 190 | 131 | 6 | 0b7200897b2c389632c9b1ee37e272b811555dbc | |
| ToppCell | facs-Lung-EPCAM-24m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.11e-05 | 190 | 131 | 6 | 8cda09d761c6b504a744959d587c183f94f1beeb | |
| ToppCell | severe_COVID-19-RBC|severe_COVID-19 / disease group, cell group and cell class (v2) | 2.11e-05 | 190 | 131 | 6 | 3a5723c2daf58c1932edd70910db4b8b30f63f42 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.18e-05 | 191 | 131 | 6 | 509230f50568e5a8ecf08edc4d58f9e2aa96efe9 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.18e-05 | 191 | 131 | 6 | 44a9a6768084dafc641ad455b65862bfd4cc0cb9 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.18e-05 | 191 | 131 | 6 | 36467322096bc766cd777dae3bfb4e65511e492c | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.18e-05 | 191 | 131 | 6 | a261f0738d974784bbdd60f23092bfbcca464459 | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.18e-05 | 191 | 131 | 6 | 094c9d3270fc1e487ccf10fb4936af5f081f6009 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.18e-05 | 191 | 131 | 6 | beb5bb42bd53bce01339da9110d374901548793c | |
| ToppCell | droplet-Lung-18m-Mesenchymal-fibroblast-alveolar_fibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.18e-05 | 191 | 131 | 6 | 94795daf05061baa3b72a1b01c9e940af86de044 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.18e-05 | 191 | 131 | 6 | 6594398cc8151c73696391a43ac110c10283dab1 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.18e-05 | 191 | 131 | 6 | 6609d85fd2577633dcc067507304a6f9e5865ca3 | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast-alveolar_fibroblast|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.18e-05 | 191 | 131 | 6 | 80484d39f34703a33b9bac09826b7a526e883cab | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.18e-05 | 191 | 131 | 6 | 7853ac7dff649150e6ff27cd4c8cf7c1fc034ed4 | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.18e-05 | 191 | 131 | 6 | 5c4e4e9de14edfae072a2a2882220a31bebf51b2 | |
| ToppCell | P03-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.18e-05 | 191 | 131 | 6 | b978afe76754cc56e1672abca27be289bb56375b | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.18e-05 | 191 | 131 | 6 | 0b3dbbc35d9970d3c749aef16dda59886b960e3d | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.18e-05 | 191 | 131 | 6 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | severe_COVID-19-RBC|World / disease group, cell group and cell class (v2) | 2.24e-05 | 192 | 131 | 6 | 1b4e28fd2e3d70ab48dbe96b280d35395889fbe2 | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-05 | 192 | 131 | 6 | df56c3e3bb1aafc1126607f4426554c09c8c40cf | |
| ToppCell | 10x3'2.3-week_12-13-Hematopoietic-erythroid|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.24e-05 | 192 | 131 | 6 | 6ace9a34ed264583042156ed61c2cb3504a331d2 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.24e-05 | 192 | 131 | 6 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.24e-05 | 192 | 131 | 6 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 2.24e-05 | 192 | 131 | 6 | 60b1312e84f6d6448365a952469c506c00b5fe93 | |
| ToppCell | NS-critical-d_0-4-Lymphoid-NK|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.31e-05 | 193 | 131 | 6 | 1b29525c5936d1b779253b8c20f059fa091c6127 | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-hematologic-erythrocytic-erythrocyte|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.31e-05 | 193 | 131 | 6 | 305e15ee467826ee08b2617c69f250ad39c11b19 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.31e-05 | 193 | 131 | 6 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | ILEUM-inflamed-(8)_Smooth_muscle_cells|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.31e-05 | 193 | 131 | 6 | 084c88f08ce0ecd6c9f4334caed370eb2154f896 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | 2.31e-05 | 193 | 131 | 6 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.31e-05 | 193 | 131 | 6 | abdfb8b1dbdcb424042e21017a9e829fced4457e | |
| ToppCell | wk_08-11-Hematologic-Meg-ery-Definitive_erythroblast|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.31e-05 | 193 | 131 | 6 | be75abfdf5301cf33df8ee9ed92504d44fdf19a6 | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 2.31e-05 | 193 | 131 | 6 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-hematologic-erythrocytic|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.31e-05 | 193 | 131 | 6 | dd376664906caccc9c2065f8e7a364509e18a5cc | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.38e-05 | 194 | 131 | 6 | e93de9428c986b8943fc169258847c650cfab0e5 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-05 | 194 | 131 | 6 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.38e-05 | 194 | 131 | 6 | 71d3c7448b1734de54187f902f65649f9283bd4c | |
| Drug | Phensuximide [86-34-0]; Down 200; 21.2uM; MCF7; HT_HG-U133A | RAD51 KIF13B ITFG2 TENT5C SCAPER MACF1 RND2 FHL1 NUP160 TOP3A | 1.76e-07 | 194 | 130 | 10 | 3521_DN |
| Drug | LY 294002; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.84e-07 | 195 | 130 | 10 | 5213_DN | |
| Drug | Merbromin [129-16-8]; Down 200; 5uM; PC3; HT_HG-U133A | 2.23e-07 | 199 | 130 | 10 | 7398_DN | |
| Drug | 15d-PGJ2; Down 200; 10uM; PC3; HT_HG-U133A | 1.78e-06 | 194 | 130 | 9 | 4455_DN | |
| Drug | Mephentermine hemisulfate [1212-72-2]; Up 200; 9.4uM; MCF7; HT_HG-U133A | 2.29e-06 | 200 | 130 | 9 | 3425_UP | |
| Drug | Dihydroergotamine tartrate [5989-77-5]; Down 200; 3uM; PC3; HT_HG-U133A | 1.49e-05 | 192 | 130 | 8 | 2081_DN | |
| Drug | Kaempferol [520-18-3]; Down 200; 14uM; PC3; HT_HG-U133A | 1.55e-05 | 193 | 130 | 8 | 5839_DN | |
| Drug | Tiaprofenic acid [33005-95-7]; Down 200; 15.4uM; MCF7; HT_HG-U133A | 1.61e-05 | 194 | 130 | 8 | 4171_DN | |
| Drug | Rapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A | 1.61e-05 | 194 | 130 | 8 | 1632_UP | |
| Drug | Hydralazine hydrochloride [304-20-1]; Down 200; 20.4uM; MCF7; HT_HG-U133A | 1.67e-05 | 195 | 130 | 8 | 2311_DN | |
| Drug | Dequalinium dichloride [522-51-0]; Down 200; 7.6uM; MCF7; HT_HG-U133A | 1.73e-05 | 196 | 130 | 8 | 5396_DN | |
| Drug | Perhexiline maleate [6724-53-4]; Down 200; 10.2uM; PC3; HT_HG-U133A | 1.73e-05 | 196 | 130 | 8 | 5081_DN | |
| Drug | Lisinopril [83915-83-7]; Down 200; 9uM; MCF7; HT_HG-U133A | 1.73e-05 | 196 | 130 | 8 | 5504_DN | |
| Drug | Methyldopa (L,-) [555-30-6]; Up 200; 19uM; MCF7; HT_HG-U133A | 1.80e-05 | 197 | 130 | 8 | 5637_UP | |
| Drug | Mevalonic-D, L acid lactone [674-26-0]; Up 200; 30.8uM; MCF7; HT_HG-U133A | 1.80e-05 | 197 | 130 | 8 | 3459_UP | |
| Drug | Xylazine [7361-61-7]; Down 200; 18.2uM; PC3; HT_HG-U133A | 1.80e-05 | 197 | 130 | 8 | 4066_DN | |
| Drug | Trifluoperazine dihydrochloride [440-17-5]; Down 200; 8.4uM; HL60; HT_HG-U133A | 1.80e-05 | 197 | 130 | 8 | 2389_DN | |
| Drug | Citalopram hydrobromide [59729-32-7]; Down 200; 1uM; PC3; HT_HG-U133A | 1.80e-05 | 197 | 130 | 8 | 3820_DN | |
| Drug | Pilocarpine nitrate [148-72-1]; Up 200; 14.8uM; HL60; HT_HG-U133A | 1.80e-05 | 197 | 130 | 8 | 2438_UP | |
| Drug | Tolbutamide [64-77-7]; Down 200; 14.8uM; MCF7; HT_HG-U133A | 1.86e-05 | 198 | 130 | 8 | 2320_DN | |
| Drug | Propafenone hydrochloride [34183-22-7]; Down 200; 10.6uM; PC3; HT_HG-U133A | 1.86e-05 | 198 | 130 | 8 | 6336_DN | |
| Drug | Dibucaine [85-79-0]; Down 200; 11.6uM; PC3; HT_HG-U133A | 1.93e-05 | 199 | 130 | 8 | 4068_DN | |
| Drug | PF-00875133-00 [351322-64-0]; Up 200; 10uM; PC3; HT_HG-U133A | 1.93e-05 | 199 | 130 | 8 | 5928_UP | |
| Drug | AC1NS44W | 2.39e-05 | 60 | 130 | 5 | CID005353385 | |
| Drug | phorone | 3.30e-05 | 106 | 130 | 6 | ctd:C018637 | |
| Drug | HA100 | 7.87e-05 | 15 | 130 | 3 | CID000003545 | |
| Drug | lenalidomide | 7.99e-05 | 77 | 130 | 5 | CID000216326 | |
| Drug | molybdenum | 8.29e-05 | 181 | 130 | 7 | CID000023932 | |
| Drug | 6,7-dimethoxyquinoline | 9.67e-05 | 3 | 130 | 2 | CID010856252 | |
| Drug | 4-aminopyrimidine-5-carbaldehyde | 9.67e-05 | 3 | 130 | 2 | CID011228787 | |
| Drug | Phenoxybenzamine hydrochloride [63-92-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 1.09e-04 | 189 | 130 | 7 | 5248_DN | |
| Drug | Pindolol [13523-86-9]; Down 200; 16.2uM; PC3; HT_HG-U133A | 1.20e-04 | 192 | 130 | 7 | 4496_DN | |
| Drug | Dizocilpine maleate [77086-22-7]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 1.20e-04 | 192 | 130 | 7 | 6223_DN | |
| Drug | Griseofulvin [126-07-8]; Down 200; 11.2uM; HL60; HT_HG-U133A | 1.24e-04 | 193 | 130 | 7 | 2332_DN | |
| Drug | Clobetasol propionate [25122-46-7]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 1.24e-04 | 193 | 130 | 7 | 6835_DN | |
| Drug | Metanephrine hydrochloride DL [881-95-8]; Down 200; 17.2uM; HL60; HG-U133A | 1.24e-04 | 193 | 130 | 7 | 2015_DN | |
| Drug | Levodopa [59-92-7]; Down 200; 20.2uM; MCF7; HT_HG-U133A | 1.24e-04 | 193 | 130 | 7 | 4394_DN | |
| Drug | Muramic acid, N-acetyl [10597-89-4]; Down 200; 13.6uM; MCF7; HT_HG-U133A | 1.24e-04 | 193 | 130 | 7 | 4406_DN | |
| Drug | Corticosterone [50-22-6]; Down 200; 11.6uM; HL60; HT_HG-U133A | 1.28e-04 | 194 | 130 | 7 | 1307_DN | |
| Drug | Tocopherol (R,S) [10191-41-0]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 1.28e-04 | 194 | 130 | 7 | 4961_UP | |
| Drug | Tacrine hydrochloride hydrate [1684-40-8]; Up 200; 15.8uM; HL60; HT_HG-U133A | 1.28e-04 | 194 | 130 | 7 | 1278_UP | |
| Drug | Chlorzoxazone [95-25-0]; Up 200; 23.6uM; PC3; HT_HG-U133A | 1.28e-04 | 194 | 130 | 7 | 2100_UP | |
| Drug | Naproxen [22204-53-1]; Down 200; 17.4uM; MCF7; HT_HG-U133A | 1.28e-04 | 194 | 130 | 7 | 5457_DN | |
| Drug | Fenbufen [36330-85-5]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 1.32e-04 | 195 | 130 | 7 | 2308_DN | |
| Drug | Mexiletine hydrochloride [5370-01-4]; Up 200; 18.6uM; HL60; HT_HG-U133A | 1.32e-04 | 195 | 130 | 7 | 2364_UP | |
| Drug | oxaprozin; Down 200; 300uM; MCF7; HT_HG-U133A_EA | 1.32e-04 | 195 | 130 | 7 | 863_DN | |
| Drug | Cisapride [81098-60-4]; Down 200; 8.6uM; PC3; HT_HG-U133A | 1.32e-04 | 195 | 130 | 7 | 6706_DN | |
| Drug | Mevalonic-D, L acid lactone [674-26-0]; Down 200; 30.8uM; MCF7; HT_HG-U133A | 1.32e-04 | 195 | 130 | 7 | 3459_DN | |
| Drug | Trimethobenzamide hydrochloride [554-92-7]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 1.32e-04 | 195 | 130 | 7 | 4180_DN | |
| Drug | Dydrogesterone [152-62-5]; Down 200; 12.8uM; HL60; HT_HG-U133A | 1.32e-04 | 195 | 130 | 7 | 2156_DN | |
| Drug | Tranylcypromine hydrochloride [1986-47-6]; Down 200; 23.6uM; MCF7; HT_HG-U133A | 1.32e-04 | 195 | 130 | 7 | 2264_DN | |
| Drug | Liothyronine [6893-02-3]; Down 200; 6.2uM; MCF7; HT_HG-U133A | 1.32e-04 | 195 | 130 | 7 | 4947_DN | |
| Drug | ST021200; Up 200; 10uM; MCF7; HT_HG-U133A | 1.32e-04 | 195 | 130 | 7 | 7554_UP | |
| Drug | Pantothenic acid calcium salt monohydrate [63409-48-3]; Up 200; 8uM; HL60; HT_HG-U133A | 1.36e-04 | 196 | 130 | 7 | 1311_UP | |
| Drug | Levodopa [59-92-7]; Down 200; 20.2uM; PC3; HT_HG-U133A | 1.36e-04 | 196 | 130 | 7 | 4571_DN | |
| Drug | Cholecalciferol [67-97-0]; Down 200; 10.4uM; HL60; HT_HG-U133A | 1.36e-04 | 196 | 130 | 7 | 2436_DN | |
| Drug | Trimipramine maleate salt [521-78-8]; Down 200; 9.8uM; MCF7; HT_HG-U133A | 1.36e-04 | 196 | 130 | 7 | 3342_DN | |
| Drug | Methylprednisolone, 6-alpha [83-43-2]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 1.36e-04 | 196 | 130 | 7 | 3183_DN | |
| Drug | SC-58125; Down 200; 10uM; SKMEL5; HG-U133A | 1.36e-04 | 196 | 130 | 7 | 507_DN | |
| Drug | Folic acid [59-30-3]; Down 200; 9uM; HL60; HG-U133A | 1.36e-04 | 196 | 130 | 7 | 1790_DN | |
| Drug | Flufenamic acid [530-78-9]; Up 200; 14.2uM; MCF7; HT_HG-U133A | 1.41e-04 | 197 | 130 | 7 | 5478_UP | |
| Drug | 9-deoxy-9-methylene-16,16-dimethyl Prostaglandin E2; Up 200; 10uM; MCF7; HT_HG-U133A | 1.41e-04 | 197 | 130 | 7 | 7500_UP | |
| Drug | Melatonin [73-31-4]; Up 200; 17.2uM; MCF7; HT_HG-U133A | 1.41e-04 | 197 | 130 | 7 | 3293_UP | |
| Drug | Gemfibrozil [25812-30-0]; Down 200; 16uM; MCF7; HT_HG-U133A | 1.41e-04 | 197 | 130 | 7 | 2277_DN | |
| Drug | Nalbuphine hydrochloride [23277-43-2]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 1.41e-04 | 197 | 130 | 7 | 7177_UP | |
| Drug | Eserine sulfate, physostigmine sulfate [64-47-1]; Down 200; 6.2uM; MCF7; HT_HG-U133A | 1.41e-04 | 197 | 130 | 7 | 2768_DN | |
| Drug | Scopolamin-N-oxide hydrobromide [6106-81-6]; Down 200; 10uM; MCF7; HT_HG-U133A | 1.41e-04 | 197 | 130 | 7 | 2262_DN | |
| Drug | Trichlormethiazide [133-67-5]; Down 200; 10.6uM; HL60; HT_HG-U133A | 1.41e-04 | 197 | 130 | 7 | 2998_DN | |
| Drug | Dropropizine (R,S) [17692-31-8]; Down 200; 17uM; MCF7; HT_HG-U133A | 1.45e-04 | 198 | 130 | 7 | 5531_DN | |
| Drug | Liothyronine [6893-02-3]; Up 200; 6.2uM; MCF7; HT_HG-U133A | 1.45e-04 | 198 | 130 | 7 | 4947_UP | |
| Drug | Isopyrin hydrochloride [18342-39-7]; Up 200; 14.2uM; MCF7; HT_HG-U133A | 1.45e-04 | 198 | 130 | 7 | 7233_UP | |
| Drug | 2-propylpentanoic acid; Up 200; 1000uM; MCF7; HT_HG-U133A | 1.45e-04 | 198 | 130 | 7 | 6969_UP | |
| Drug | Ambroxol hydrochloride [23828-92-4]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 1.45e-04 | 198 | 130 | 7 | 5319_UP | |
| Drug | Proparacaine hydrochloride [5875-06-9]; Down 200; 12uM; PC3; HT_HG-U133A | 1.45e-04 | 198 | 130 | 7 | 6332_DN | |
| Drug | Griseofulvin [126-07-8]; Down 200; 11.2uM; PC3; HT_HG-U133A | 1.45e-04 | 198 | 130 | 7 | 7363_DN | |
| Drug | Propidium iodide [25535-16-4]; Down 200; 6uM; HL60; HT_HG-U133A | 1.45e-04 | 198 | 130 | 7 | 2541_DN | |
| Drug | Benzydamine hydrochloride [132-69-4]; Up 200; 11.6uM; HL60; HG-U133A | 1.50e-04 | 199 | 130 | 7 | 1552_UP | |
| Drug | (R) -Naproxen sodium salt [26159-34-2]; Up 200; 15.8uM; MCF7; HT_HG-U133A | 1.50e-04 | 199 | 130 | 7 | 6794_UP | |
| Drug | Folinic acid calcium salt [6035-45-6]; Down 200; 7.8uM; MCF7; HT_HG-U133A | 1.50e-04 | 199 | 130 | 7 | 4725_DN | |
| Drug | Levamisole hydrochloride [16595-80-5]; Down 200; 16.6uM; MCF7; HT_HG-U133A | 1.50e-04 | 199 | 130 | 7 | 2257_DN | |
| Drug | Diltiazem hydrochloride [33286-22-5]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 1.50e-04 | 199 | 130 | 7 | 5309_DN | |
| Drug | Iproniazide phosphate [305-33-9]; Down 200; 14.4uM; MCF7; HT_HG-U133A | 1.50e-04 | 199 | 130 | 7 | 5458_DN | |
| Drug | Palmatine chloride [3486-67-7]; Up 200; 10.4uM; MCF7; HT_HG-U133A | 1.50e-04 | 199 | 130 | 7 | 4957_UP | |
| Drug | 2-propylpentanoic acid; Up 200; 50uM; MCF7; HT_HG-U133A | 1.50e-04 | 199 | 130 | 7 | 6941_UP | |
| Drug | Lomefloxacin hydrochloride [98079-52-8]; Down 200; 10.4uM; MCF7; HT_HG-U133A | 1.50e-04 | 199 | 130 | 7 | 2310_DN | |
| Drug | Gibberellic acid [77-06-5]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 1.54e-04 | 200 | 130 | 7 | 4818_DN | |
| Drug | Palmatine chloride [3486-67-7]; Down 200; 10.4uM; PC3; HT_HG-U133A | 1.54e-04 | 200 | 130 | 7 | 6612_DN | |
| Drug | monomethylarsonous acid | RAD51 MYLK PDGFRA ITFG2 SYNE1 IREB2 HMGCR NCOA4 FBLN1 BPGM EGFR TSPAN4 TOP3A | 1.74e-04 | 694 | 130 | 13 | ctd:C406082 |
| Drug | AC1O52TD | 1.93e-04 | 4 | 130 | 2 | CID006451138 | |
| Drug | Phenylurea Compounds | 1.93e-04 | 4 | 130 | 2 | ctd:D010671 | |
| Drug | 3-bromoaniline | 1.93e-04 | 4 | 130 | 2 | CID000011562 | |
| Drug | aminoflavone | 1.93e-04 | 20 | 130 | 3 | CID000389710 | |
| Drug | androstenediol | 2.57e-04 | 54 | 130 | 4 | CID000010634 | |
| Disease | blue cone monochromacy (implicated_via_orthology) | 3.38e-10 | 4 | 128 | 4 | DOID:0050679 (implicated_via_orthology) | |
| Disease | muscular disease (is_implicated_in) | 1.58e-06 | 6 | 128 | 3 | DOID:0080000 (is_implicated_in) | |
| Disease | Myopathy | 8.48e-06 | 30 | 128 | 4 | C0026848 | |
| Disease | Cone monochromatism | 1.87e-05 | 2 | 128 | 2 | cv:C0339537 | |
| Disease | BORNHOLM EYE DISEASE | 1.87e-05 | 2 | 128 | 2 | C3159311 | |
| Disease | Achromatopsia incomplete, X-linked | 1.87e-05 | 2 | 128 | 2 | C2931753 | |
| Disease | Red-green dyschromatopsia | 1.87e-05 | 2 | 128 | 2 | cv:C0155016 | |
| Disease | Cone monochromatism | 1.87e-05 | 2 | 128 | 2 | C0339537 | |
| Disease | BLUE CONE MONOCHROMACY | 1.87e-05 | 2 | 128 | 2 | 303700 | |
| Disease | blue cone monochromacy (is_implicated_in) | 1.87e-05 | 2 | 128 | 2 | DOID:0050679 (is_implicated_in) | |
| Disease | Cancer of Head | 1.51e-04 | 24 | 128 | 3 | C0751177 | |
| Disease | Head Neoplasms | 1.51e-04 | 24 | 128 | 3 | C0018675 | |
| Disease | Upper Aerodigestive Tract Neoplasms | 1.51e-04 | 24 | 128 | 3 | C0887900 | |
| Disease | Neck Neoplasms | 1.71e-04 | 25 | 128 | 3 | C0027533 | |
| Disease | Cancer of Neck | 1.71e-04 | 25 | 128 | 3 | C0746787 | |
| Disease | Waldenstrom macroglobulinemia | 1.85e-04 | 5 | 128 | 2 | EFO_0009441 | |
| Disease | Cone-Rod Dystrophy 2 | 2.68e-04 | 29 | 128 | 3 | C3489532 | |
| Disease | Emery-Dreifuss muscular dystrophy | 2.77e-04 | 6 | 128 | 2 | cv:C0410189 | |
| Disease | trem-like transcript 1 protein measurement | 2.77e-04 | 6 | 128 | 2 | EFO_0803193 | |
| Disease | Muscular Dystrophy, Emery-Dreifuss | 2.77e-04 | 6 | 128 | 2 | C0410189 | |
| Disease | mean corpuscular hemoglobin concentration | FLOT2 TTC28 ANP32B TENT5C IREB2 MYO1B NCOA4 EGFR ASB3 OTUD4 MACF1 EIF2AK4 EXOC2 TXNDC8 | 3.24e-04 | 1105 | 128 | 14 | EFO_0004528 |
| Disease | Neurodevelopmental delay | 3.87e-04 | 7 | 128 | 2 | C4022738 | |
| Disease | X-Linked Emery-Dreifuss Muscular Dystrophy | 3.87e-04 | 7 | 128 | 2 | C0751337 | |
| Disease | Head and Neck Neoplasms | 3.96e-04 | 33 | 128 | 3 | C0018671 | |
| Disease | hemorrhoid | 4.64e-04 | 147 | 128 | 5 | EFO_0009552 | |
| Disease | Mammary Carcinoma, Human | 4.90e-04 | 525 | 128 | 9 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 4.90e-04 | 525 | 128 | 9 | C1257931 | |
| Disease | Mammary Neoplasms | 5.03e-04 | 527 | 128 | 9 | C1458155 | |
| Disease | arteriosclerosis (biomarker_via_orthology) | 5.14e-04 | 8 | 128 | 2 | DOID:2349 (biomarker_via_orthology) | |
| Disease | triglyceride change measurement, response to simvastatin, response to fenofibrate | 5.56e-04 | 37 | 128 | 3 | EFO_0007681, GO_1901557, GO_1903491 | |
| Disease | Breast Carcinoma | 5.83e-04 | 538 | 128 | 9 | C0678222 | |
| Disease | cup-to-disc ratio measurement | 5.95e-04 | 430 | 128 | 8 | EFO_0006939 | |
| Disease | prostate adenocarcinoma (is_marker_for) | 8.21e-04 | 10 | 128 | 2 | DOID:2526 (is_marker_for) | |
| Disease | FEV/FEC ratio | COL6A3 CTTNBP2 ZC3H11B IREB2 NSMCE2 ATP13A2 GAB2 FBLN1 GTF2I SCAPER OTUD4 KDR EXOC2 DEUP1 | 9.12e-04 | 1228 | 128 | 14 | EFO_0004713 |
| Disease | Malignant Head and Neck Neoplasm | 9.27e-04 | 44 | 128 | 3 | C0278996 | |
| Disease | Gastrointestinal Diseases | 1.20e-03 | 12 | 128 | 2 | C0017178 | |
| Disease | Functional Gastrointestinal Disorders | 1.20e-03 | 12 | 128 | 2 | C0559031 | |
| Disease | Cholera Infantum | 1.20e-03 | 12 | 128 | 2 | C1565321 | |
| Disease | Cardiomyopathy, Familial Idiopathic | 1.35e-03 | 50 | 128 | 3 | C1449563 | |
| Disease | open-angle glaucoma | 1.50e-03 | 191 | 128 | 5 | EFO_0004190 | |
| Disease | Drug habituation | 1.61e-03 | 115 | 128 | 4 | C0013170 | |
| Disease | Drug abuse | 1.61e-03 | 115 | 128 | 4 | C0013146 | |
| Disease | Prescription Drug Abuse | 1.61e-03 | 115 | 128 | 4 | C4316881 | |
| Disease | Substance-Related Disorders | 1.61e-03 | 115 | 128 | 4 | C0236969 | |
| Disease | Drug Use Disorders | 1.61e-03 | 115 | 128 | 4 | C0013222 | |
| Disease | Drug Dependence | 1.61e-03 | 115 | 128 | 4 | C1510472 | |
| Disease | Substance Dependence | 1.61e-03 | 115 | 128 | 4 | C0038580 | |
| Disease | Substance Use Disorders | 1.61e-03 | 115 | 128 | 4 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 1.61e-03 | 115 | 128 | 4 | C0029231 | |
| Disease | breast carcinoma | ZBTB38 TTC28 POLR2B SLC6A15 ADAM30 ZC3H11A GTF2I BAIAP2L1 EGFR PLXNC1 SEMA4A BAHCC1 | 1.63e-03 | 1019 | 128 | 12 | EFO_0000305 |
| Disease | Substance abuse problem | 1.66e-03 | 116 | 128 | 4 | C0740858 | |
| Disease | intraocular pressure measurement | 1.75e-03 | 509 | 128 | 8 | EFO_0004695 | |
| Disease | N-acetyl-beta-alanine measurement | 2.15e-03 | 16 | 128 | 2 | EFO_0021430 | |
| Disease | Polyposis, Adenomatous Intestinal | 2.15e-03 | 16 | 128 | 2 | C2713442 | |
| Disease | Familial Intestinal Polyposis | 2.15e-03 | 16 | 128 | 2 | C2713443 | |
| Disease | muscular dystrophy (is_implicated_in) | 2.43e-03 | 17 | 128 | 2 | DOID:9884 (is_implicated_in) | |
| Disease | Adenomatous Polyposis Coli | 2.43e-03 | 17 | 128 | 2 | C0032580 | |
| Disease | Astigmatism | 2.45e-03 | 129 | 128 | 4 | HP_0000483 | |
| Disease | Malignant neoplasm of breast | RAD51 NSD2 SYNE1 NSMCE2 ZC3H11A CSF3 EGFR TSPAN4 ZNF432 MACF1 KDR HNRNPR | 2.52e-03 | 1074 | 128 | 12 | C0006142 |
| Disease | Hemangiosarcoma | 2.73e-03 | 18 | 128 | 2 | C0018923 | |
| Disease | carcinoma (implicated_via_orthology) | 2.74e-03 | 64 | 128 | 3 | DOID:305 (implicated_via_orthology) | |
| Disease | pulse pressure measurement | COL6A3 FLOT2 TTC28 PDGFRA ZC3H11B CR1L SYT10 NEK9 CCT6A PLXNC1 ASB3 EIF2AK4 FHL1 NUP160 | 2.92e-03 | 1392 | 128 | 14 | EFO_0005763 |
| Disease | breast carcinoma (is_marker_for) | 2.99e-03 | 66 | 128 | 3 | DOID:3459 (is_marker_for) | |
| Disease | Hereditary Non-Polyposis Colon Cancer Type 2 | 3.04e-03 | 19 | 128 | 2 | C1333991 | |
| Disease | Colorectal cancer, hereditary nonpolyposis, type 1 | 3.04e-03 | 19 | 128 | 2 | C2936783 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 3.20e-03 | 139 | 128 | 4 | DOID:3908 (is_implicated_in) | |
| Disease | cortical thickness | FLOT2 CTTNBP2 SLC6A15 MSH3 GLOD4 ATP13A2 BPGM EGFR PLXNC1 MACF1 EXOC2 CLUH | 3.36e-03 | 1113 | 128 | 12 | EFO_0004840 |
| Disease | response to COVID-19 vaccine, SARS-CoV-2 neutralizing antibody measurement | 3.37e-03 | 20 | 128 | 2 | EFO_0803359, EFO_0803362 | |
| Disease | Intellectual Disability | 3.44e-03 | 447 | 128 | 7 | C3714756 | |
| Disease | cardiomyopathy (implicated_via_orthology) | 3.68e-03 | 71 | 128 | 3 | DOID:0050700 (implicated_via_orthology) | |
| Disease | migraine disorder, endometriosis | 3.97e-03 | 73 | 128 | 3 | EFO_0001065, MONDO_0005277 | |
| Disease | response to alcohol | 4.29e-03 | 75 | 128 | 3 | EFO_0005526 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VCGDSDKGFVVINQK | 281 | P40227 | |
| GVQKFDLGIICVDNK | 31 | P58557 | |
| GGLKASCIQQEAKFL | 656 | Q9P281 | |
| KVLDACDGKFQAIDF | 381 | Q8NDM7 | |
| ACVKKLLESGADVNQ | 181 | Q96DX5 | |
| FGAVIKVQNKLDGCC | 601 | Q9P2K8 | |
| FKQQAVCGNAKLEAG | 381 | Q99965 | |
| KELLAVACEQFLGKN | 81 | Q14254 | |
| LQKGESVKFQLCVLG | 646 | O75534 | |
| NCKSNDGKIEGLTAE | 26 | Q92688 | |
| ELLKIGECQNAQGNK | 296 | Q05D60 | |
| EQFCKSFENGIGKEL | 81 | P23786 | |
| NEGKDFCGNKIVENK | 336 | Q6ZP01 | |
| NCILQLFGKKVDDGS | 331 | P04000 | |
| NCILQLFGKKVDDGS | 331 | P0DN78 | |
| VGDKCQVRLDHNGKF | 286 | Q01804 | |
| GNKICQFKLVLLGES | 16 | P51148 | |
| CGINANDVKKLEEAG | 31 | Q06609 | |
| ACLNEKVGFKGFQIA | 466 | P48200 | |
| LCAQKAKAALNGADI | 216 | Q8WVV9 | |
| NCILQLFGKKVDDGS | 331 | P0DN77 | |
| LAQGKIVKICDFGLA | 826 | P16234 | |
| VDCIFSLAKVAKQGD | 831 | P20585 | |
| KNGLCIDKSFICDGQ | 121 | Q86YD5 | |
| GLYKCVAKNDAGQAE | 1166 | Q15746 | |
| KLCDFGFAKIDQGDL | 166 | Q8IW41 | |
| EKLQGKAIRQVSCGD | 421 | Q8TD19 | |
| QGKALKVFEAEQFGC | 201 | Q8NFG4 | |
| GYADNQCKLELQGVK | 191 | Q9HC38 | |
| EECLQILGNAEKGAK | 446 | P04035 | |
| DNCKKLGLVFDNVVG | 376 | P40123 | |
| CVLKNAELKFNFGEE | 231 | Q92499 | |
| KGTVGFENQINKCLE | 471 | Q99259 | |
| EGEGLKNVIFTNCVK | 101 | Q9BT17 | |
| DCDTIGQAKEKIFQA | 1226 | O60486 | |
| VCRVGQAKNDKGDII | 61 | Q96KP1 | |
| GEGQFEKLCQESAKQ | 286 | O96028 | |
| ITFCGKEAAQEAVKL | 211 | O43390 | |
| LKKQCGLQADREADG | 136 | Q96MF7 | |
| FGTCGEEQKTVLQEK | 1866 | O94854 | |
| NVFLKACEQIGLKEA | 126 | Q8WWI1 | |
| AEIGCLKNLKELNVG | 161 | Q9BYS8 | |
| GVAALCEGLKQKNSV | 1081 | P59047 | |
| CGKQLKALNFEFDLV | 41 | P07738 | |
| ASLLEGEENTCGKQK | 546 | Q76FK4 | |
| GGEAQAKKLGNNCVF | 46 | Q99714 | |
| GDVCNKGKNLLVAVS | 71 | Q969R8 | |
| FKGFNDGLEELCKIQ | 656 | Q9UPT5 | |
| NCILQLFGKKVDDGS | 331 | P04001 | |
| KGVEIENLGNLKCLN | 356 | Q13772 | |
| KLQCKSGFIQDALGN | 291 | P23142 | |
| CKGCFKAIVAGDQNV | 101 | Q13642 | |
| GAGEENCQKLTKIIC | 201 | P00533 | |
| LLKKEQFGNQVCGLS | 161 | Q9UKF2 | |
| INLGGKLQLVCFDKT | 501 | Q9NQ11 | |
| LRKGANKECQDDFGI | 166 | Q9Y575 | |
| SCKNLKGGLQEVAEQ | 201 | Q9UIV1 | |
| NGVCEDQLGKAAKEA | 1241 | Q9ULT8 | |
| IKGKDLCLFCAEIQG | 66 | Q9NZH7 | |
| LKLQGSQDNIGKDTC | 86 | Q9NZH7 | |
| DIGLKNALGCENKGF | 86 | Q8N954 | |
| NALGCENKGFALLQK | 91 | Q8N954 | |
| QSEIQKFIADGCKEA | 171 | Q9UHR4 | |
| FVNLKNVVCKIGEDA | 226 | Q14185 | |
| GNKECIKLLLEAGTN | 821 | Q8WZ74 | |
| GDFIKCVEQKTDALG | 116 | Q5TC12 | |
| GAKVDFVCDEGFQLK | 371 | Q2VPA4 | |
| GGNENKFGSQKECEK | 3146 | P12111 | |
| EDVFGQLQLQGCKKI | 91 | Q9NPH9 | |
| KDDFLGAAEGKLQCN | 766 | Q69YH5 | |
| KCLEQVRKIQGDGAA | 46 | P09919 | |
| QNFCDGFLSGKLLKE | 246 | Q96DN0 | |
| SCKNLKGGLQEVADQ | 201 | Q9UFF9 | |
| FLKQGCGEDKICQSN | 676 | Q13683 | |
| KVENLFNEKCGEALG | 736 | P78347 | |
| FNEKCGEALGLKQAV | 741 | P78347 | |
| KGKCLGSQDYLELAN | 1366 | Q9BY12 | |
| YGENEDNRIGLKVCK | 151 | Q8IZK6 | |
| NVENFLDACKKLGVS | 711 | Q5VUJ6 | |
| LGGKVTIECAKNNFQ | 551 | Q9H0X9 | |
| AFNPALGADCKGQVK | 66 | Q9Y4I5 | |
| CEQVDAGLTFNKKEL | 66 | Q9UQC2 | |
| IKVGDDKCFLVNLNA | 441 | Q9NQT8 | |
| FIGLVNCSEGIKNQK | 26 | Q7RTR8 | |
| SKVLGGSFADQKICQ | 1711 | Q93008 | |
| CKIEEELNKAVQGTG | 426 | Q9H2J7 | |
| LEEKNKGNECFQKGD | 361 | P31948 | |
| DQKVLGEELDGCNSK | 5461 | Q8NF91 | |
| LKAVVEKVNGCLGRN | 236 | Q6ZMZ3 | |
| CLQAKDGISVKGANN | 381 | P23415 | |
| ARVCKNDVGGEKLLQ | 266 | Q9H3S1 | |
| LIECLQGKVSANKGE | 981 | P30876 | |
| ILKKSGCGRQIDEAN | 146 | Q92185 | |
| FECNDQVVKGKEAGE | 636 | P11215 | |
| AEKLFKQALKAGDGC | 256 | Q9NRC1 | |
| LAFKCIKLQFGGEAA | 1246 | Q12769 | |
| CKAIIQGKQFEGLVD | 791 | P63128 | |
| VKDNGLGCKDLDLIF | 81 | Q5VWP2 | |
| KQQLTDQGNGKCIDF | 151 | Q8IYA6 | |
| QAKVQQGFLKEGCEL | 986 | O75153 | |
| AECGKTALLQVFAKD | 16 | P52198 | |
| KECGKAFNQSSGLII | 511 | Q8IYB9 | |
| SEQCSLDGKKLGAQA | 371 | Q5D1E8 | |
| KLQNRCVGKDGEGDL | 51 | Q96NA8 | |
| GGDSKFLAENNKLCE | 851 | Q7Z3J2 | |
| NECGKAFGLKSQLII | 391 | Q14587 | |
| KEQRKFCLAAEGLGN | 31 | Q15413 | |
| AVNIKQGECLNFGIK | 201 | O75152 | |
| QAISIGKNCDKFGIV | 226 | Q9Y6L7 | |
| SEGNQNEDVKICGKL | 221 | Q6XYQ8 | |
| NLIFEFCGADAKKLE | 106 | Q6A555 | |
| VLCVAEKNDAAKGIA | 36 | Q13472 | |
| AVNIKQGECLHFGIK | 201 | A0A1B0GTU1 | |
| AIGFVGCLGAIKENK | 66 | O14817 | |
| ALGNLGDIFICKKDI | 716 | Q96AY4 | |
| NLFGGTAAKKQTLCL | 581 | Q641Q2 | |
| FGEGKNQLKNENGCK | 596 | Q9UJ78 | |
| LGNKAILYDDKGACL | 31 | Q86YA3 | |
| FNQNDKGCIKGSVLI | 441 | Q86YA3 | |
| NECGKGFAFKSNLVV | 516 | O94892 | |
| QKEVAGGCAAQSKDI | 866 | Q9UI33 | |
| LSEKNVVKICDFGLA | 1036 | P35968 | |
| KLQCELCDGDKAVGA | 981 | Q8NAP3 | |
| GNGDCALLCKEELKQ | 21 | Q6XPR3 | |
| VEQLRKEGNELFKCG | 21 | Q9H3U1 | |
| GKVCGQCENKAALLV | 131 | A8MT70 | |
| VKLLIQLADGFCEKG | 1196 | O75962 | |
| GEKLQLFCQEDGKVI | 101 | Q9C030 | |
| KECGKAFSQNTGLIL | 381 | Q15776 | |
| KECGKAFNGNTGLIQ | 521 | Q15776 | |
| CEKTAVEFGNQLEGK | 81 | Q6ZMS7 | |
| SECGKGFIQKGNLNI | 321 | Q9BS31 | |
| LEGQAATLKCKAIGD | 301 | Q9ULH4 | |
| DNGFAKLKNICVLSA | 106 | A6PVS8 | |
| AAVCGKGAEVNQVKE | 126 | O43795 | |
| SKQKGDAVLQCGHVF | 956 | Q8N1T3 | |
| FNELIKNCNKHDGRG | 316 | Q5VVJ2 | |
| LGFKEGQTIKLCIGN | 151 | Q8NC96 |